Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (30)

2024

  1. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers

    Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53

  3. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  4. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

2022

  1. Ten steps to eliminating hepatitis C in hospitals

    Nature Reviews Gastroenterology and Hepatology

2021

  1. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  2. The front labelling of food: Nutritional traffic lights, nutri-score and others

    European Food and Feed Law Review, Vol. 16, Núm. 2, pp. 104-111

2020

  1. The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300

2018

  1. Impact of human-Associated Escherichia coli clonal groups in Antarctic pinnipeds: Presence of ST73, ST95, ST141 and ST131

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Biofilm formation and quorum-sensing-molecule production by clinical isolates of Serratia liquefaciens

    Applied and Environmental Microbiology, Vol. 81, Núm. 10, pp. 3306-3315

  2. Comparison of various SYSADOA for the osteoarthritis treatment: An experimental study in rabbits Clinical rheumatology and osteoporosis

    BMC Musculoskeletal Disorders, Vol. 16, Núm. 1

2014

  1. Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis

    BMC Veterinary Research, Vol. 10

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  2. Clinical impact of HTLV-1 infection in Spain: Implications for public health and mandatory screening [3]

    Journal of Acquired Immune Deficiency Syndromes

1998

  1. Genetic analysis of human immunodeficiency virus type 2 strains from spain

    AIDS Research and Human Retroviruses